The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Lilly
Travel, Accommodations, Expenses - Amgen
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Proacta; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Proacta; Tesaro
Vemurafenib in patients with BRAFV600 mutant glioma: A cohort of the histology-independent VE-basket study.
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics; Chugai Pharma; CytomX Therapeutics
Research Funding - AstraZeneca; Puma Biotechnology
 
Thomas Joseph Kaley
No Relationships to Disclose
 
Antoine Hollebecque
No Relationships to Disclose
 
Vivek Subbiah
Research Funding - Novartis, GSK, Nanocarrier, NorthWest Biotherapeutics, Roche/Genentech, BergPharma, Bayer, Incyte, FujiFilm, Pharmamar, D3, Pfizer Amgen, Abbvie, Multivir, Bluprint Medicines.
Travel, Accommodations, Expenses - Novartis, Pharmamar, Fujifilm
 
Jordi Rodon Ahnert
Consulting or Advisory Role - Lilly/ImClone; Novartis; SERVIER
 
A. Craig Lockhart
No Relationships to Disclose
 
Vicki Leigh Keedy
Employment - Zimmer BioMet (I)
Consulting or Advisory Role - Janssen Oncology; Karyopharm Therapeutics; Threshold Pharmaceuticals
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); eleison pharmaceuticals (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Janssen (Inst); Lilly (Inst); medpacto (Inst); pfizer (Inst); Plexxikon (Inst); Roche (Inst); Threshold Pharmaceuticals (Inst)
 
Ralf Hofheinz
No Relationships to Disclose
 
Florence Joly Lobbedez
No Relationships to Disclose
 
Jean-Yves Blay
Consulting or Advisory Role - Roche
Research Funding - Roche (Inst)
 
Ian Chau
Honoraria - Amgen; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi
 
Igor Puzanov
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Merck
 
Noopur Raje
Consulting or Advisory Role - Amgen; Celgene; Novartis; Takeda
Research Funding - AstraZeneca
Other Relationship - Amgen; Lilly; Proacta
 
Juergen Wolf
No Relationships to Disclose
 
Martina Makrutzki
Employment - Proacta
 
Todd Riehl
Employment - Genentech
 
Bethany Pitcher
Employment - Proacta
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - Eli Lilly, Novartis; GRAIL